Recursion Pharmaceuticals: Q3 Earnings Snapshot

SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Wednesday reported a loss of $162.3 million in its third quarter.

The Salt Lake City-based company said it had a loss of 36 cents per share.

The biotechnology company posted revenue of $5.2 million in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $17.4 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RXRX at https://www.zacks.com/ap/RXRX